Crab blood to remain big pharma’s standard as industry group rejects substitute
Horseshoe crabs’ icy-blue blood will remain the drug industry’s standard for safety tests after a powerful US group ditched a plan to give equal status to a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups. The crabs’ copper-rich blood clots in the...